anti-PD-1 - Globe Thesis

Keyword [anti-PD-1] Result: 21 - 40 \| Page: 2 of 6
21.	Efficacy And Safety Of Anti-PD-1 Antibody In Advancedesophageal Squamous Cell Carcinoma
22.	Preparation And Biological Function Of Anti-PD-1/IL-15/IL-15Rα Bifunctional Fusion Protein
23.	The Influence Of Anti-PD-1 On Prion Disease
24.	The Impact Of Antibiotics On Efficacy Of Anti-PD-1 Therapy In Solid Tumors
25.	The Experimental Study Of The Efficacy Of Chemotherapy Combined With Anti-PD-1 Antibody In The Treatment Of Lewis Lung Cancer Xenograft Mice And The Mechanism Of Regulating The Immune Function
26.	Efficacy And Safety Of Anti-PD-1 Monoclonal Antibody In The Treatment Of Advanced Malignant Tumors
27.	Correlation Of Serum Immune-related Cytoki Ne Levels Between Efficacy And Prognosis In Patients With Advanced Non-small Cell Lung Cancer During Anti-PD-1 Therapy
28.	Anti-tumor Activity Of Anti-PD-1 Antibody In Lewis Lung Carcinoma Mouse Model
29.	Study On The Effect And Mechanism Of Apatinib Alone And Combination With Anti-PD-1 Antibody In The Treatment Of Colon Cancer
30.	Study Of Low Dose Chemotherapy On Tumor Immune Micro-environment And Its Antitumor Effect With Anti-PD-1 Monoclonal Antibody In The Gastric Carcinoma Xenograft Model
31.	Analysis Of The Relationship Between Peripheral Blood Markers And The Outcome Of Patients With Advanced Non-small Cell Lung Cancer After Anti-PD-1 Immunotherapy
32.	Pembrolizumab-an Anti-PD-1 Agent In Treatment Of Tripe Negative Breast Cancer: Recent Findings And Next Move
33.	Expression And Significance Of MMR/MSI In Medullary Thyroid Carcinoma And Analysis Of Prognostic Factors
34.	A Clinical Study Of Anti-PD-1 Antibody Combined With Pemetrexed As Second-or Further-line Treatment For Advanced Refractory Lung Adenocarcinoma
35.	Mechanism Of Metformin Downregulates PD-L1 Expression In Esophageal Squamous Cell Carcinoma By Inhibiting IL-6 Signaling Pathway
36.	Correlation Between Combined Fibrinogen And Neutrophil-lymphocyte Ratio And The Efficacy And Prognosis In Advanced Malignant Melanoma Patients Treated With Anti-PD-1 Antibody
37.	The Application Of Agrocybe Aegerita Lectin In Tumor Therapy And Tumor Diagnosis
38.	The Role Of YAP Phase Separation In Tumor Resistance To Immunotherapy
39.	Nanocarriers Regulating Tumor Microenvironment For Sensitizing Anti-PD-1 Immunotherapy
40.	Efficacy And Mechanism Study Of Anti-PD-1 Therapy Synergizing With Combretastatin A4 Nanoparticles Plus DC101 In Hepatocellular Carcinoma
<<First <Prev Next> Last>> Jump to